Senzime AB (publ) (STO:SEZI)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.63
+0.03 (0.45%)
Aug 14, 2025, 5:29 PM CET

Senzime AB Company Description

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States.

It provides TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue’s opposition to carrying an alternating electrical current.

The company has a strategic connectivity and licensing agreement with Masimo to develop, manufacture, market, and distribute products that can connect to the Masimo Root patient monitoring system and related digital hub for data transmission to hospital electronic patient journals; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system.

Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.

Senzime AB (publ)
Senzime AB logo
CountrySweden
Founded1999
IndustryMedical Devices
SectorHealthcare
Employees54
CEOPhilip Siberg

Contact Details

Address:
Vaksalagatan 6
Uppsala, 756 51
Sweden
Phone46 18 51 56 40
Websitesenzime.com

Stock Details

Ticker SymbolSEZI
ExchangeNasdaq Stockholm
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0002478776
SIC Code3845

Key Executives

NamePosition
Philip SibergChief Executive Officer
Slavoljub GrujicicChief Financial Officer
Johanna TulkkiExecutive Vice President and Chief Operating Officer
Anders JacobsonChief Scientific Officer
Paula TreutigerHead of Communication and Investor Relations
Michael NobleVice President Global Marketing
Catrin MolundExecutive Vice President of Business Development
Johanna FarisHead of Q/RA/S
G.W HamiltonPresident of Senzime Inc